CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cefotetan And Dextrose In Duplex Container patents expire, and when can generic versions of Cefotetan And Dextrose In Duplex Container launch?
Cefotetan And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER is cefotetan disodium. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
Summary for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Patent Applications: | 933 |
DailyMed Link: | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
US Patents and Regulatory Information for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER | cefotetan disodium | INJECTABLE;INJECTION | 065430-001 | Aug 9, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER | cefotetan disodium | INJECTABLE;INJECTION | 065430-002 | Aug 9, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |